Physiological role of naturally-occuring amyloid beta oligomers
天然存在的β淀粉样蛋白寡聚体的生理作用
基本信息
- 批准号:9759747
- 负责人:
- 金额:$ 19.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-15 至 2021-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAlzheimer&aposs DiseaseAmino Acid SequenceAmyloid beta-ProteinAnimal ModelAnimalsBiologyBrainBrain DiseasesChickensDangerousnessDementiaDevelopmentDiseaseEmbryoEtiologyEvolutionExperimental ModelsEye diseasesGlaucomaHomoHumanImmunohistochemistryIn VitroLinkMacular degenerationMemory impairmentMicrogliaModelingNatureNeurologicOryctolagus cuniculusPathogenicityPathologicPathologyPatternPeptidesPhysiologicalRegulationRetinaRoleSerineSiteSynapsesTestingTherapeuticTimeWestern Blottingabeta oligomerbrain tissuecellular developmentexperimental studyganglion cellhuman modelinsightnanomolarneuroinflammationneuron lossneuropathologynon-dementednonhuman primaterelating to nervous systemselective expressionsynaptic pruningtau Proteinstau phosphorylationtau-1
项目摘要
Surprisingly, evolution has retained an amino acid sequence for the human Aβ42 peptide that favors formation
of large homo-oligomers. It is widely regarded that these unusual molecules are pathogenic. These oligomers
accumulate in human and animal model brain tissue in an Alzheimer's disease-dependent manner. They have
been shown experimentally to impact the CNS in a manner that causes memory dysfunction and recapitulates
AD neuropathology (e.g., tau hyperphosphorylation, neuroinflammation, synapse loss, selective nerve cell
death). Pathological AβO buildup begins early in the disease, before plaques, but it is not evident in healthy,
non-demented adults. In vitro, toxic AβOs readily assemble from nanomolar concentrations of synthetic human
Aβ. The same oligomer-forming sequence is found in certain animal species (e.g., nonhuman primates, rabbit,
chicken, but not rodents). It is peculiar that these species have retained the apparently dangerous capacity to
form molecules that instigate the neural damage leading to AD dementia. The current project addresses the
possibility that circumstances exist whereupon AβOs manifest a functional, physiological presence. In the long-
run, determining such circumstances is expected to give a significantly new perspective into the triggers and
mechanisms of toxic AβO buildup in AD. The working hypothesis tested is that AβOs have a transient, functional
role during CNS development, a possibility strongly supported by preliminary findings. Western blots and
immunohistochemistry show the presence of AβOs in the developing chick, whose Aβ sequence is the same as
humans. AβOs in embryonic retina are selectively expressed by ganglion cells, which, somewhat remarkably,
likewise show a presence of tau phosphorylated at the AD serine-396 site. Nothing is known about the function
of the developmentally-regulated AβOs, but it is feasible that the developmental impact may resemble the
pathological impact observed in adult brain. Looked at another way, when AβOs re-emerge pathologically in
adults, they impact brain tissue in a manner re-capitulating developmental functions. Developmental functions
of AβOs thus might comprise, e.g., stimulation of tau hyperphosphorylation, microgliosis, synaptic pruning or
selective nerve cell death. The Aims test the hypothesis using developing chick retina for experimentation.
Aim 1 Determine the onset, peak expression and disappearance pattern for particular AβO species relative
to AD-like tau hyperphosphorylation and microglial differentiation during retina development.
Aim 2 Determine the influence that transient AβOs exert on cellular development of retina, particularly with
respect to microglia and tau hyperphosphorylation.
Results are expected to establish that Alzheimer's-related AβOs serve a physiological role during development.
Embryonic chick will be introduced as an exceptionally well-suited model for investigating the regulation of AβO
expression and normal AβO function, including its relationship to tau and microglia. By achieving the first insights
into normal AβO biology, it is expected that new and deeper insight into AβO pathobiology will be achieved.
令人惊讶的是,进化保留了有利于形成的人类Aβ42肽的氨基酸序列
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
An Essential Role for Alzheimer's-Linked Amyloid Beta Oligomers in Neurodevelopment: Transient Expression of Multiple Proteoforms during Retina Histogenesis.
- DOI:10.3390/ijms23042208
- 发表时间:2022-02-17
- 期刊:
- 影响因子:5.6
- 作者:Bartley SC;Proctor MT;Xia H;Ho E;Kang DS;Schuster K;Bicca MA;Seckler HS;Viola KL;Patrie SM;Kelleher NL;De Mello FG;Klein WL
- 通讯作者:Klein WL
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM L KLEIN其他文献
WILLIAM L KLEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM L KLEIN', 18)}}的其他基金
Development of a non-fibrillic amyloid-beta oligomer selective positron emission tomography imaging diagnostic for Alzheimer.
开发用于阿尔茨海默氏症的非纤维状淀粉样蛋白-β寡聚物选择性正电子发射断层扫描成像诊断。
- 批准号:
9202960 - 财政年份:2016
- 资助金额:
$ 19.29万 - 项目类别:
A novel, nanoparticle-based molecular MRI probe for early Alzheimer's diagnostics
一种用于早期阿尔茨海默病诊断的新型纳米粒子分子 MRI 探针
- 批准号:
8842908 - 财政年份:2014
- 资助金额:
$ 19.29万 - 项目类别:
A novel, nanoparticle-based molecular MRI probe for early Alzheimer's diagnostics
一种用于早期阿尔茨海默病诊断的新型纳米粒子分子 MRI 探针
- 批准号:
8683797 - 财政年份:2014
- 资助金额:
$ 19.29万 - 项目类别:
Alzheimer's Drug Discovery Using Unique Nanotechnology Platform
使用独特的纳米技术平台发现阿尔茨海默病药物
- 批准号:
8548221 - 财政年份:2012
- 资助金额:
$ 19.29万 - 项目类别:
Alzheimer's Drug Discovery Using Unique Nanotechnology Platform
使用独特的纳米技术平台发现阿尔茨海默病药物
- 批准号:
8446087 - 财政年份:2012
- 资助金额:
$ 19.29万 - 项目类别:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
ADDL、突触
- 批准号:
7615522 - 财政年份:2007
- 资助金额:
$ 19.29万 - 项目类别:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
ADDL、突触
- 批准号:
7184209 - 财政年份:2007
- 资助金额:
$ 19.29万 - 项目类别:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
ADDL、突触
- 批准号:
7470605 - 财政年份:2007
- 资助金额:
$ 19.29万 - 项目类别:
Abeta oligomers (ADDLs) in Alzheimers Disease pathology
阿尔茨海默病病理学中的 Abeta 寡聚物 (ADDL)
- 批准号:
6678227 - 财政年份:2003
- 资助金额:
$ 19.29万 - 项目类别:
Abeta oligomers (ADDLs) in Alzheimer's Disease pathology
阿尔茨海默病病理学中的 Abeta 寡聚物 (ADDL)
- 批准号:
7805554 - 财政年份:2003
- 资助金额:
$ 19.29万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 19.29万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 19.29万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 19.29万 - 项目类别:
Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 19.29万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 19.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 19.29万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 19.29万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 19.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 19.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 19.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




